Skip to content
Following a overview of 108 circumstances reported international, Europe’s drugs regulator introduced on Thursday {that a} uncommon nerve-degeneration dysfunction, Guillain-Barré syndrome, were added as a imaginable uncommon aspect impact of Johnson & Johnson’s Covid-19 vaccine.
